# PAX Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pax-labs

- Industry: Consumer Products
- Headquarters: San Francisco, US
- Website: www.paxvapor.com
- Total disclosed funding: $47M
- Latest round: Series C (Jun 10, 2015)
- Investors on record: 4

## About

PAX Labs Inc. is a company that develops and distributes innovative cannabis vaporization products and edibles, focusing on quality and technology to enhance consumer experiences in cannabis consumption.PAX Labs Inc. was founded in 2007 and is headquartered in San Francisco, US. The company specializes in vaporization technology and has undergone strategic pivots to focus on cannabis products. Salim Al Busaidi is the founder, and the company has successfully raised USD 420.00 mn in funding, with a current valuation of USD 1,700.00 mn. Investors in their latest funding round include Evolution VC Partners, Prescott General Partners, Redmile Group, Tao Capital Partners, and Tiger Global Management.PAX Labs, Inc. specializes in the development and distribution of premium cannabis products, focusing on innovative vaporization technology and edibles. The company's core offerings include a range of portable vaporizers, such as the PAX MINI and PAX PLUS, designed for the efficient consumption of cannabis in a discrete manner. Additionally, PAX provides high-quality cannabis edibles, notably all-natural gummies infused with Delta-9 THC, catering to consumers seeking alternative methods of cannabis consumption. These products are primarily targeted at adult users aged 21 and older in various U.S. markets, where recreational and medicinal cannabis use is permitted. PAX Labs emphasizes consistent quality and memorable experiences, driven by their passion for the cannabis plant and a commitment to science-backed formulations.PAX Labs generates revenue through direct-to-consumer and retail channel sales of its cannabis vaporization devices and edibles. The company's business structure involves selling its flagship products, such as the PAX vaporizers and high purity gummies, to both individual consumers and retail partners. Transactions typically occur in a one-time purchase format, with customers buying products directly from the PAX website or authorized retailers. The pricing strategy is designed to capture a wide range of consumer preferences, offering premium products that reflect the quality and innovation associated with the PAX brand. This diverse sales approach allows PAX to maintain a robust revenue stream while fostering brand loyalty among cannabis users across its operational markets.PAX Labs Inc. is focusing on expanding its product line with upcoming launches of new vaporization devices and edibles aimed at enhancing consumer experience. The company is targeting expansion into new markets, specifically looking at regions with emerging cannabis legislation to establish a presence by the end of 2024. Recent funding of USD 420.00 mn will support these growth initiatives and facilitate the development of innovative products that align with consumer preferences.

## Funding rounds

- Series C, Jun 10, 2015, $47M — Fidelity Investments, Sand Hill Angels, Tao Capital Partners, Sivia Capital

## Investors

- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C
- Sand Hill Angels (https://capitalatlas.ai/funds/sand-hill-angels) — Series C
- Tao Capital Partners (https://capitalatlas.ai/funds/tao-capital-partners) — Series C
- Sivia Capital — Series C